CASOLI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 1.528
EU - Europa 1.142
AS - Asia 886
SA - Sud America 68
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 3.637
Nazione #
US - Stati Uniti d'America 1.470
CN - Cina 405
SG - Singapore 323
UA - Ucraina 228
IE - Irlanda 216
SE - Svezia 198
FI - Finlandia 179
DE - Germania 124
HK - Hong Kong 102
BR - Brasile 61
CA - Canada 52
NL - Olanda 51
FR - Francia 39
TR - Turchia 39
GB - Regno Unito 38
IT - Italia 32
BE - Belgio 14
RU - Federazione Russa 8
EU - Europa 5
MX - Messico 5
IN - India 4
PK - Pakistan 4
CI - Costa d'Avorio 3
UZ - Uzbekistan 3
AT - Austria 2
BD - Bangladesh 2
CO - Colombia 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
NO - Norvegia 2
PY - Paraguay 2
VN - Vietnam 2
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.637
Città #
Jacksonville 232
Dublin 216
Chandler 204
Singapore 186
Beijing 112
Santa Clara 112
Hong Kong 102
Dearborn 95
Ann Arbor 82
Boardman 74
Nanjing 69
Ashburn 62
Helsinki 49
Princeton 48
San Mateo 48
Shanghai 46
Toronto 39
Izmir 38
Wilmington 34
Los Angeles 22
Shenyang 22
Hebei 20
Woodbridge 20
Kunming 19
Seattle 19
Hefei 17
Nanchang 16
Brussels 14
Falkenstein 14
Jinan 14
New York 13
Changsha 10
Tianjin 10
Jiaxing 9
Norwalk 8
Auburn Hills 7
Guangzhou 6
Moscow 6
Parma 6
Bremen 5
Columbus 5
Hangzhou 4
Rio de Janeiro 4
Rockville 4
São Paulo 4
Taiyuan 4
Abidjan 3
Dallas 3
Houston 3
Montreal 3
Munich 3
Rome 3
San Francisco 3
Tashkent 3
Xian 3
Amsterdam 2
Belo Horizonte 2
Centuripe 2
Chennai 2
Des Moines 2
Düsseldorf 2
Fortaleza 2
Frankfurt am Main 2
Islamabad 2
Isorella 2
London 2
Luxembourg 2
Montréal 2
Newark 2
Ningbo 2
Nuremberg 2
Oslo 2
Ponta Porã 2
Pune 2
Redwood City 2
Stockholm 2
The Dalles 2
Vienna 2
Zhengzhou 2
Abelardo Luz 1
Aracaju 1
Arapiraca 1
Asunción 1
Atlanta 1
Baku 1
Barquisimeto 1
Bhanga 1
Bibbiano 1
Blumenau 1
Bogotá 1
Brasília 1
Bratislava 1
Brno 1
Brooklyn 1
Byron 1
Camapuã 1
Campinas 1
Campo Belo 1
Carapicuíba 1
Cascavel 1
Totale 2.246
Nome #
Biological insight into the mechanism of action of thiosemicarbazone complexes. 138
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 122
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 112
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection. 103
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 99
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 95
HTLV-II influence on AIDS progression and changes in response to antiretroviral therapy in Italian IDUs coinfected with HIV-1 93
Exposure of TF-1 cells to HTLV-II induces the activation of STAT1 and STAT5 through the secretion of IFN-g and GM-CSF 93
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 93
HTLV-II infection exerts a protective role against AIDS progression in IDUs coinfected with HIV-1 90
Screening of HIV-1 Isolates By Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy 88
HIV e riproduzione umana 85
HTLV-II Downregulates HIV-1 replication in IL-2 Stimulated PBMC Cultures of Co-infected Individuals Through Expression of MIP-1a 85
Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression? 82
Expression of cytokines and of chemokine receptors in PBMCs of HTLV-II mono-infected and HTLV-II/HIV-1 co-infected individuals 81
Azione concertata ELVIS: espressione selettiva della chemochina CCL3L1 in soggetti LTNP co-infettati da HIV-1 e HTLV-2 79
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 79
Epidemiological and molecular data on 170 HTLV-2 cases of Italian IDUs 78
Un mimotopo sintetico killer, attivo nei confronti di patogeni opportunisti correlati ad AIDS inibisce l’infezione esogena ed endogena di HIV 77
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of CCL3L1 75
Delayed progression to aids in HTLV-2/HIV-1 coinfected intravenous drug users 74
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of the CCL3/MIP-1alpha isoform L1/LD78beta 73
Up-regulation of the LD78b isoform of MIP-1a in PBMC cultures obtained from HTLV-2 infected/HIV-1 exposed seronegative individuals 73
La coinfezione HIV-1/HTLV-II è associata ad un rallentamento della progressione AIDS 72
Anti-CD4-GP120 complex antibodies in long term non progressors HIV-1 positive patients: a role in slowing disease progression?  71
Negative interference of HTLV-II on HIV-1 replication via CC chemokines 70
Human T-cell Leukemia virus type II (HTLV-II) induces STAT1 and STAT5 activation in CD34+ TF-1 cells 70
A dual defensive role of CIITA against retroviral infections 70
Retroviral cross-talk: HTLV-II Downregulates HIV-1 Replication from PBMC Cultures of Co-infected Individuals Via MIP-1a 70
HTLV-2 influence on pathways regulating proliferation and death in B cell line BJAB 68
HTLV-II Replication inversely correlates with the expression of CIITA, the major regulator of HLA class II transcription 67
PBMC expression of cytokines and chemokine receptors in relation to AIDS progression and HTLV-II co-infection 67
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures 67
Human T-cell leukemia virus type II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of Interferon-g and Granulocyte Macrophage-Colony Stimulating Facto 67
Selective CCL3L1/LD78b production by PBMCs during HTLV-2 infection induces resistance to HIV-1 entry 65
Serological and clinical follow-up of an Italian IVDU cohort of HTLV-II/HIV-1 co-infected patients. Evidence of direct relationship between CD4 count and HTLV-II proviral load 64
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells 64
Specificity of the reverse Heteroduplex Mobility Assay (rHMA) for the identification of HIV-1 non-B clades in the new AIDS epidemic in Italy sustained by sexual transmission 62
The MHC class II transactivator: prey and hunter in infectious diseases 61
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 61
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 59
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 59
The origin and evolution of Human T-cell Lymphotropic virus type II (HTLV-II) and the relationship with its replication 57
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 56
HTLV-II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of IFN-g and GM-CSF 56
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA, il regolatore trascrizionale dell’espressione dell’HLA-II 55
The MHC Class II Transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection 54
Inhibition of human T cell leucemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y 47
Totale 3.646
Categoria #
all - tutte 13.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 0 0 0 51
2020/2021388 6 55 51 3 55 4 48 4 91 11 56 4
2021/2022250 3 8 1 9 18 1 35 48 7 19 45 56
2022/2023786 92 96 51 63 66 70 12 37 262 4 22 11
2023/2024252 22 33 2 4 28 49 18 23 12 6 13 42
2024/2025869 4 56 59 52 75 148 4 18 152 82 49 170
Totale 3.646